Status:
COMPLETED
Study on Psychoeducation Enhancing Results of Adherence in Schizophrenia
Lead Sponsor:
University of Cagliari
Conditions:
Patient Non-Compliance
Schizophrenia and Related Disorders
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Background: Psychosis in the spectrum of schizophrenia (PSS) are severe mental disorders, with a high impact on disability and participation. Poor adherence to pharmacotherapy negatively impacts on th...
Eligibility Criteria
Inclusion
- diagnosis of psychosis in the spectrum of schizophrenia (ICD-10: F20 to F29); -age from 18 to 55;
- being in care for 2 years or more.
Exclusion
- mental retardation, or any severe cognitive impairment;
- psychosis due to substance abuse or to a medical condition;
- affective psychosis;
- comorbid substance dependence;
- patient does not understand Italian language;
- pharmacotherapy with depot.
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT01433094
Start Date
September 1 2012
End Date
December 1 2016
Last Update
September 11 2017
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Università Degli Studi Di Urbino "Carlo Bo"
Urbino, Urbino/Pesaro, Italy
2
Università Degli Studi Di Bari
Bari, Italy
3
Fatebenefratelli Irccs
Brescia, Italy
4
Azienda Universitaria Ospedaliera Cagliari
Cagliari, Italy